Recent ITCI Stock Price | ITCI Stock Predictions | |
$127.82 | ![]() -1.82% |
$125.50 |
Recent ITCI Analyst Ratings Breakdown, Making ITCI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 5 | 6 | 11 | 11 |
Buy ratings: | 0 | 1 | 2 | 2 |
Hold ratings: | 10 | 8 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.33 | 2.13 | 1.4 | 1.4 |
For the ITCI stock predictions from the analysts covering Intra-Cellular Therapies Inc, we have collected all of the individual ITCI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 14 different analysts covering ITCI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ITCI stock predictions may vary widely, another useful metric to consider is the median ITCI stock prediction, which represents the price at which half of the analysts
made ITCI stock predictions that were higher and half made ITCI stock predictions that were lower. This makes for a different take on the ITCI stock predictions out there, as compared to average or mean.
And that median across all the individual ITCI stock predictions was: $132.0 as of 2025-02-18.
The very highest of the ITCI stock predictions for one year price target was $140.0, while the very lowest of the ITCI stock predictions in the analyst group was
$74.0 (with a standard deviation of $17.01). Get the latest Zacks research report on ITCI — FREE
Find out: ITCI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CRDF Stock Predictions
BOOT Stock Predictions
GMAB Stock Predictions
GLPI Stock Predictions
LH Stock Predictions
VGR Stock Predictions
DCPH Stock Predictions
RAPT Stock Predictions
RHP Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Buy (2.67 out of 4) 13rd percentile
(ranked lower than approx. 87% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |